Bladder Pain Syndrome – An Evolution

1. Introduction
Philip Hanno, David Staskin, Alan Wein, Jørgen Nordling, Jean Jacques Wyndaele

2. Historical Perspectives
Jane Meijlink

3. The Epidemiology of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS): How Good Was a Study of 30-Years Ago
Philip J. Held, Philip Hanno, Frank McCormick

4. Epidemiology Commentary
J. Curtis Nickel

5. The Prevalence of Bladder Pain Syndrome/Interstitial Cystitis in Italy: The importance of a National Registry
Loredana Nasta

6. Interstitial Cystitis: Animal Models
Tony Buffington, Michael R. Ruggieri, David J. Klumpp

7. Etiology: Etiological and Pathogenic Theories of Interstitial Cystitis/Bladder Pain Syndrome
Jørgen Nordling, David Staskin, Naoki Yoshimura

8. Differences in Clinical Features and Histopathology in BPS/IC with and without Hunner Lesions
Christina Kåbjörn-Gustafsson, Ralph Peeker

9. Mast Cells and Interstitial Cystitis
Frank Aldenborg, Magnus Fall, Lennart Enerbäck

10. Mast Cells as Biomarkers for Bladder Pain Syndrome/Interstitial Cystitis?
Marianne Gamper, Sigrid Regauer, Volker Viereck

11. Diagnosis of Interstitial Cystitis: A Clinical, Endoscopic and Pathologic Approach
Joop P. Merwe

12. Diagnosis of Interstitial Cystitis: A Comment on Glomerulations
Gjertrud Egge Wennevik

13. Diagnosis of Interstitial Cystitis
Jörgen Quaghebeur

14. Commentary on Sant Chapter: 30 Years on!
Grannum R. Sant

15. Neuro-Urologic Evaluation in Interstitial Cystitis
Jean Jacques Wyndaele

16. Current Role of Neurourologic Evaluation in Interstitial Cystitis/Bladder Pain Syndrome
Hann-Chorng Kuo

17. Neurourological Evaluation in BPS
Arndt Ophoven

18. Bladder Hydrodistension in 2017
Claus Riedl

19. Pharmacologic Goals in Interstitial Cystitis/Bladder Pain Syndrome
Antonella Giannantoni, Marilena Gubbiotti, Naoki Yoshimura, Karl-Erik Andersson

20. Intravesical Therapy of Interstitial Cystitis
Philip Hanno

21. Botulinum Toxin in Treatment of Bladder Pain Syndrome/Interstitial Cystitis
Paulo Dinis

22. Intravesical Therapy and Its Evolution Over Three Decades, A European View
Mauro Cervigni

23. The Use of Heparin
Arndt Ophoven

24. What Happened to Eosinophilic Cationic Protein: A Dead End
Philip Hanno

25. The Use of Pentosan Polysulfate in the Management of Interstitial Cystitis
Robert M. Moldwin

26. Etiology of Interstitial Cystitis and the Role of Pentosanpolysulfate in IC Therapy
C. Lowell Parsons

27. Use of Transcutaneous Electrical Nerve Stimulation in the Management of Bladder Pain Syndrome
Magnus Fall

28. Use of Transcutaneous Electrical Nerve Stimulation in the Management of Bladder Pain Syndrome: 2017 Update
Kenneth M. Peters

29. Reappraisal of Transurethral Resection in Classic Interstitial Cystitis
Magnus Fall

30. Treatment of Interstitial Cystitis with the Neodymium YAG Laser: A Swedish View
Magnus Fall

31. Treatment of Interstitial Cystitis with the Neodymium YAG Laser: The Russian View
Andrew Zaitcev

32. Partial Denervation Procedures for Bladder Pain Syndrome
Rajesh Taneja

33. Surgical Therapy of Bladder Pain Syndrome
Tomohiro Ueda, Jørgen Nordling, Ralph Peeker, Magnus Fall

34. The Birth of Conservative Management, Prescription Drug Applications, and Pelvic Floor Physical Therapy
Rebecca Rinko, Nima Shah, Melissa Dawson, Kristene Whitmore

35. Placing Interstitial Cystitis/Bladder Pain Syndrome on the Map: The Story of the Interstitial Cystitis Association
Vicki Ratner

36. Back to the Future: Looking Forward by Examining the Past
John W. Kusek, Chris Mullins

37. Afterword
Philip Hanno, Alan Wein

Keywords: Medicine & Public Health, Urology